Review
Published on 30 Sep 2022
Associating resistance to immune checkpoint inhibitors with immunological escape in colorectal cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.987302
- 3,780 views
- 2 citations
Type at least 3 characters
1,334 articles
Articles
Original Research
Published on 29 Sep 2022
LASTR is a novel prognostic biomarker and predicts response to cancer immunotherapy in gastric cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1020255
- 2,759 views
- 1 citation
Original Research
Published on 28 Sep 2022
The impact of macrophages on endothelial cells is potentiated by cycling hypoxia: Enhanced tumor inflammation and metastasis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.961753
- 2,964 views
- 6 citations
Original Research
Published on 28 Sep 2022
NOX4 has the potential to be a biomarker associated with colon cancer ferroptosis and immune infiltration based on bioinformatics analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.968043
- 4,000 views
- 10 citations
Review
Published on 27 Sep 2022
Role of Interleukin-1 family in bone metastasis of prostate cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.951167
- 3,397 views
- 9 citations
Original Research
Published on 27 Sep 2022
Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.995651
- 2,933 views
- 5 citations
Original Research
Published on 26 Sep 2022
Pembrolizumab vs cemiplimab for the treatment of advanced non-small cell lung cancer with PD-L1 expression levels of at least 50%: A network meta-analysis and cost-effectiveness analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.878054
- 7,482 views
- 6 citations
Review
Published on 23 Sep 2022
Antitumor effects of Chinese herbal medicine compounds and their nano-formulations on regulating the immune system microenvironment
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.949332
- 6,780 views
- 18 citations
Case Report
Published on 23 Sep 2022
Pathological complete response in MMR-deficient/MSI-high and KRAS-mutant patient with locally advanced rectal cancer after neoadjuvant chemoradiation with immunotherapy: A case report
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.926480
- 3,295 views
- 3 citations
Mini Review
Published on 23 Sep 2022
Intracellular radar: Understanding γδ T cell immune surveillance and implications for clinical strategies in oncology
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1011081
- 2,824 views
- 5 citations
Original Research
Published on 23 Sep 2022
Focus on pattern recognition receptors to identify prognosis and immune microenvironment in colon cancer
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1010023
- 1,131 views
Original Research
Published on 21 Sep 2022
Neoadjuvant immunotherapy and neoadjuvant chemotherapy in resectable non-small cell lung cancer: A systematic review and single-arm meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.901494
- 3,844 views
- 5 citations
Original Research
Published on 15 Sep 2022
Effectiveness of a phone-based nurse monitoring assessment and intervention for chemotherapy-related toxicity: A randomized multicenter trial
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.925366
- 3,266 views
- 5 citations
Original Research
Published on 15 Sep 2022
A stratification system of ferroptosis and iron-metabolism related LncRNAs guides the prediction of the survival of patients with esophageal squamous cell carcinoma
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.1010074
- 2,294 views
- 4 citations
Original Research
Published on 14 Sep 2022
Integrated TCR repertoire analysis and single-cell transcriptomic profiling of tumor-infiltrating T cells in renal cell carcinoma identifies shared and tumor-restricted expanded clones with unique phenotypes
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.952252
- 6,248 views
- 2 citations
Review
Published on 14 Sep 2022
4-1BB: A promising target for cancer immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Oncology
doi 10.3389/fonc.2022.968360
- 17,782 views
- 26 citations